New Spins on Old Drugs: Enhancing Activity of Antifungals

摘要

In this issue ofCell Chemical Biology, describe a series of studies in the human fungal pathogenCandida albicansto identify a new target for antimicrobial drug development. Beginning with an unbiased compound screen, they identify new mechanisms to address rising resistance to currently used anti-infective agents.